Damora Therapeutics (DMRA) Gains from Sales and Divestitures (2024 - 2026)
Damora Therapeutics (DMRA) reported Gains from Sales and Divestitures of $5292.0 for Q1 2026, up 2.8% on a YoY basis from $5148.0 in Q1 2025, and down 32.15% quarter-over-quarter from $7800.0 in Q4 2025.
Damora Therapeutics (DMRA) Gains from Sales and Divestitures (2024 - 2026) Analysis & Trends
Damora Therapeutics has reported Gains from Sales and Divestitures for 3 years, with the latest figure at $5292.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Sales and Divestitures rose 2.8% year-over-year to $5292.0; the trailing twelve-month figure through Mar 2026 stood at $5292.0 (up 2.8% YoY), and the FY2025 full-year result was $7800.0, up 10.64% from the prior year.
- Gains from Sales and Divestitures for Q1 2026 stood at $5292.0, down from $7800.0 in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $17499.0 in Q2 2024, with the low at $5148.0 in Q1 2025.
- Historically, Gains from Sales and Divestitures has averaged $7820.6 across 3 years, with a median of $6939.0 in 2024.
- The largest YoY upside for Gains from Sales and Divestitures was 14.24% in 2025 against a maximum downside of 70.58% in 2025.
- Damora Therapeutics' Gains from Sales and Divestitures stood at $7050.0 in 2024, then climbed by 10.64% to $7800.0 in 2025, then tumbled by 32.15% to $5292.0 in 2026.
- The last three Gains from Sales and Divestitures figures came in at $5292.0 (Q1 2026), $7800.0 (Q4 2025), and $7800.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Damora Therapeutics | 731.26 Mn | 528.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,292.00 |
| Mar 31, 2026 | 5,292.00 |
| Dec 31, 2025 | 7,800.00 |
| Dec 31, 2025 | 7,800.00 |
| Sep 30, 2025 | 7,800.00 |
| Sep 30, 2025 | 7,800.00 |
| Jun 30, 2025 | 5,148.00 |
| Jun 30, 2025 | 5,148.00 |
| Mar 31, 2025 | 5,148.00 |
| Mar 31, 2025 | 5,148.00 |
| Dec 31, 2024 | 7,050.00 |
| Dec 31, 2024 | 7,050.00 |
| Sep 30, 2024 | 6,828.00 |
| Sep 30, 2024 | 6,828.00 |
| Jun 30, 2024 | 17,499.00 |
| Jun 30, 2024 | 17,499.00 |